Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000897069-20-000035
Filing Date
2020-01-15
Accepted
2020-01-15 16:15:10
Documents
1
Effectiveness Date
2020-01-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9815
  Complete submission text file 0000897069-20-000035.txt   10870
Mailing Address 640 N. LASALLE DRIVE SUITE 200 CHICAGO IL 60654
Business Address 640 N. LASALLE DRIVE SUITE 200 CHICAGO IL 60654 (800) 396-6463
Fibroblast, Inc. (Filer) CIK: 0001587278 (see all company filings)

EIN.: 455385914 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-358164 | Film No.: 20528438